APA

Maganti H. B., Jrade H., Cafariello C., Manias Rothberg J. L., Porter C. J., Yockell-Lelièvre J., Battaion H. L., Khan S. T., Howard J. P., Li Y., Grzybowski A. T., Sabri E., Ruthenburg A. J., Dilworth F. J., Perkins T. J., Sabloff M., Ito C. Y. & Stanford W. L. (20191108). Targeting the MTF2-MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to Chemotherapy. : Cancer discovery.

Chicago

Maganti Harinad B, Jrade Hani, Cafariello Christopher, Manias Rothberg Janet L, Porter Christopher J, Yockell-Lelièvre Julien, Battaion Hannah L, Khan Safwat T, Howard Joel P, Li Yuefeng, Grzybowski Adrian T, Sabri Elham, Ruthenburg Alexander J, Dilworth F Jeffrey, Perkins Theodore J, Sabloff Mitchell, Ito Caryn Y and Stanford William L. 20191108. Targeting the MTF2-MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to Chemotherapy. : Cancer discovery.

Harvard

Maganti H. B., Jrade H., Cafariello C., Manias Rothberg J. L., Porter C. J., Yockell-Lelièvre J., Battaion H. L., Khan S. T., Howard J. P., Li Y., Grzybowski A. T., Sabri E., Ruthenburg A. J., Dilworth F. J., Perkins T. J., Sabloff M., Ito C. Y. and Stanford W. L. (20191108). Targeting the MTF2-MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to Chemotherapy. : Cancer discovery.

MLA

Maganti Harinad B, Jrade Hani, Cafariello Christopher, Manias Rothberg Janet L, Porter Christopher J, Yockell-Lelièvre Julien, Battaion Hannah L, Khan Safwat T, Howard Joel P, Li Yuefeng, Grzybowski Adrian T, Sabri Elham, Ruthenburg Alexander J, Dilworth F Jeffrey, Perkins Theodore J, Sabloff Mitchell, Ito Caryn Y and Stanford William L. Targeting the MTF2-MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to Chemotherapy. : Cancer discovery. 20191108.